Journal
JOURNAL OF PEDIATRICS
Volume 151, Issue 4, Pages 388-393Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jpeds.2007.03.047
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR006022-10, M01 RR000069-37, M01 RR000070, M01 RR000059-42, M01 RR000069, M01 RR000070-37] Funding Source: Medline
- NICHD NIH HHS [U10 HD041908, U01 HD041890-01, U10 HD041918-01, U10 HD041915-01, U10 HD041906-01, U01 HD041890, U10 HD041919-01, U10 HD041915, U10 HD041918, U10 HD041908-01, U10 HD041906] Funding Source: Medline
Ask authors/readers for more resources
Objective To examine the feasibility of daily use of a continuous glucose monitor, the FreeStyle Navigator Continuous Glucose Monitoring System (Navigator), in children with type 1. diabetes (T1D). Study design After a masked Navigator was used for 4 to 7 days to establish a baseline level of glycemic control, 30 insulin pump users with T1D (average age 11.2 years) were asked to use the Navigator daily for 13 weeks. Results Subjects averaged 149 h/wk of Navigator use during the first 4 weeks, which decreased slightly to 134 h/wk during weeks 9 to 13 (P = .006). Mean hemoglobin Ale improved from 7.1% at baseline to 6.8% at 13 weeks (P = .02), and the percentage of glucose values between 71 and 180 mg/dL increased from 52% to 60% (P = .01). Subjects and parents reported high satisfaction with the Navigator on the Continuous Glucose Monitor Satisfaction Scale. Two subjects had severe skin reactions related to sensor mount adhesive. Conclusion This study indicates that incorporating real-time continuous glucose monitoring into the daily treatment of children with T1D is feasible. The results provide a compelling rationale for conducting a randomized trial of daily use of a continuous glucose monitor in children with T1D.
Reviews
Recommended
No Data Available